Tivic Health Systems, Inc. (TIVC)

Market Cap	3.11M
Revenue (ttm)	482,000
Net Income (ttm)	-7.55M
Shares Out	1.77M
EPS (ttm)	-9.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,930
Open	1.700
Previous Close	1.750
Day's Range	1.700 - 1.819
52-Week Range	1.470 - 15.640
Beta	1.96
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2025

About TIVC

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relie...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: TIVC
• Website: https://tivichealth.com

Financial Performance

In 2024, Tivic Health Systems's revenue was $780,000, a decrease of -33.67% compared to the previous year's $1.18 million. Losses were -$5.66 million, -31.40% less than in 2023.